News | January 22, 2008

Surgeons Demo Robotic Coronary Revascularization, Mitral Valve Repair

January 22, 3008 - Cardica Inc. and Intuitive Surgical Inc. will host an evening symposium, demonstrating how surgeons can automate the attachment of blood vessel grafts during coronary artery bypass graft (CABG) procedures, replacing traditional hand-sewn sutures.

The symposium, �Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair,� will feature Intuitive�s da Vinci Surgical System and Cardica�s C-Port Distal Anastomosis Systems. The educational event will take place on Sunday, January 27, from 7 to 9 p.m. (EST), at the Renaissance Hotel Grand Ballroom in Fort Lauderdale, FL, during the 44th Annual Meeting of The Society of Thoracic Surgeons (STS).

�This symposium offers cardiothoracic surgeons an opportunity to learn from their peers who are leading the adoption of beating heart robotic CABG surgery and the establishment of robotic mitral valve surgery as standard of care,� said Louis A. Brunsting, III, M.D., cardiothoracic surgeon for Centennial Medical Center in Nashville, Tennessee. �The Cardica C-Port systems and da Vinci Surgical System�may facilitate a more widespread adoption of completely closed-chest, robotic-assisted coronary artery bypass grafting.�

During the symposium, five cardiac surgeons will present topics, including: Husam Balkhy, M.D., of The Wisconsin Heart Hospital; Daniel Bethencourt, M.D., of Long Beach Memorial Medical Center; Louis A. Brunsting, III, M.D., of Centennial Medical Center; Douglas A. Murphy, M.D., of Saint Joseph's Hospital; J. Michael Smith, M.D., of Good Samaritan Hospital.

For more information: www.cardica.com

Related Content

Edwards Lifesciences Pascal Tricuspid Valve Transcatheter Repair System Approved in Europe
News | Heart Valve Technology | May 18, 2020
May 18, 2020 — The Edwards Lifesciences Corp.
Key TAVR Takeaways From ACC 2020
Feature | Heart Valve Technology | April 20, 2020 | Dave Fornell, Editor
Some U.S.
Abbott announced its TriClip Transcatheter Tricuspid Valve Repair (TTVR) System has received European CE mark clearance as a non-surgical treatment for people with a tricuspid valve regurgitation (TR). 
Feature | Heart Valve Technology | April 09, 2020
April 9, 2020 — Abbott announced its TriClip Transcatheter Tricuspid Valve Repair (TTVR) System has received European
The Edwards Lifesciences Cardioband for tricuspid valve regurgitation. #COVID19 #coronavirus

The Edwards Lifesciences Cardioband for tricuspid valve regurgitation is one of the device trials being paused for the duration of the COVID-19 outbreak.

News | Heart Valve Technology | March 30, 2020
March 30, 2020 — Edwards Lifesciences Corp.
Conclusions from the TAVR vs surgery trial for aortic valve replacement in the U.K. presented by William D. Toff, M.D. at ACC 20. #ACC20 #ACC2020 #TAVR #TAVR

Conclusions from the real world TAVR vs. surgery trial for aortic valve replacement outcomes in the U.K., presented by William D. Toff, M.D. at ACC 20. 

News | Heart Valve Technology | March 30, 2020
March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) di
PARTNER 3 trial shows positive results for Sapien 3 in low-risk surgical patients. #ACC20 #ACC2020 #Sapien3 #TAVR
Feature | Heart Valve Technology | March 30, 2020
March 30, 2020 — Low-risk patients undergoing transcatheter aortic valve repair (TAVR) at two years did just as well
News | Heart Valve Technology | March 29, 2020
March 29, 2020 — Worse than expected outcomes were found for survival and quality of life among patients undergoing t
Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session. #ACC20 #ACC2020
Feature | Heart Valve Technology | March 29, 2020 | Dave Fornell, Editor
March 29, 2020 — Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replace
The heart team at St. James University Hospital Dublin was the first to perform a human implant of the CroiValve Duo Tricuspid Coaptation Valve technology for tricuspid repair.  

The heart team at St. James University Hospital Dublin was the first to perform a human implant of the CroiValve Duo Tricuspid Coaptation Valve technology for tricuspid repair.  

News | Heart Valve Technology | March 25, 2020
 
A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Imagine courtesy of TeraRecon. #TAVR #TAVI

A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Image courtesy of TeraRecon

Feature | Heart Valve Technology | February 24, 2020 | Dave Fornell, Editor
In August 2019, the U.S.